首頁(yè)
瀏覽量: 152
- 產(chǎn)品名稱(chēng)： IRGD
- 產(chǎn)品貨號(hào)： CS800103
- 貨期： 現(xiàn)貨
- 價(jià)格與訂購(gòu)： 750
- 數(shù)量：
庫(kù)存： 100
- 規(guī)格： 1mg 5mg
- 產(chǎn)品信息
- 如何訂購(gòu)
產(chǎn)品描述
iRGD peptide is a 9-amino acid cyclic peptide (sequence: CRGDKGPDC) and a molecular mimicry agent that was originally identified in an in vivo screening of phage display libraries in tumor-bearing mice.
貨號(hào)（Catalog No.）
CS800103
CAS NO
1392278-76-0
序列
Cys-Arg-Gly-Asp-Lys-Gly-Pro-Asp-Cys（Cys1&Cys9 bridge）
分子式
C35H57N13O14S2
分子量
948.04
存儲(chǔ)
Powder: -20°C for 3 years
In solvent: -80°C for 6 months
純度
98.77%
靶點(diǎn)活性
Integrin
別名
c(CRGDKGPDC)
溶解度
Water: 10 mM
DMSO: Insoluble
( < 1 mg/ml refers to the product slightly soluble or insoluble )
參考文獻(xiàn)
1. Puig-Saus C, et al. iRGD tumor-penetrating peptide-modified oncolytic adenovirus shows enhanced tumor transduction, intratumoral dissemination and antitumor efficacy. Gene Ther. 2014 Aug;21(8):767-74.
2. Zhang L, et al. Combination of NRP1-mediated iRGD with 5-fluorouracil suppresses proliferation, migration and invasion of gastric cancer cells. Biomed Pharmacother. 2017 Sep;93:1136-1143.
Note
For research use only .
上一篇 mTRP-2 (180-188)
tirzepatide 下一篇
地 址：
產(chǎn)品銷(xiāo)售：
E - mail ：
郵 編：
Amily
